Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126424) titled 'Conversion Therapy for Stage III Unresectable Non-Small Cell Lung Cancer: A Prospective, Open-Label, Randomized Controlled, Multicenter Phase II Trial' on June 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai East Hospital

Condition: non small cell lung cancer

Intervention: surgery:Radical surgical resection

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-06-16

Target Sample Size: surgery:92;radiotherapy:92;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=310980

Published by HT Digital...